Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...

Unlike retailers facing bankruptcy, one particularly popular drugstore chain is closing locations for a very different reason ...

Billionaire investor and entrepreneur Mark Cuban is taking strides to overhaul the U.S. healthcare sector, beginning with his ...

Claims data also show rapid adoption of GLP-1 for weight loss, with a steady increase in utilization since 2021 and peaking ...

Novo Nordisk said on Monday all eligible cash-paying customers in the United States can buy its weight-loss drug Wegovy at a ...

Novo Nordisk (NVO) announced updates to the Wegovy savings program, allowing all eligible cash-paying patients access to Wegovy injection 0.25 ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Dozens of independent pharmacies have shuttered in Alabama over the last two years, according to the Alabama Independent ...

From his lab at the University of Houston College of Pharmacy Drug Discovery Institute, Mingfu Wu, associate professor, is offering new hope for treating heart disease by sharing his insights into the ...

Medications like Ozempic and Mounjaro work by mimicking naturally occurring hormones in the body, such as glucagon-like ...

The Office of Insurance Regulation is demanding the unusual trove of data from pharmacy benefit managers — health care ...

For the percentage of people living in pharmacy deserts in the five states that the researchers identified as having the ...